Delivery Order SPE2DB20D2104-SPE2DB23FV45W
Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $120
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred thirty-two dollars and fifty-four cents to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/mL injections. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a one-day period of performance from August 10th to 11th, 2023 at its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA-wide contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $109,440 to Amerisourcebergen Drug Corporation. The order is for the delivery of testosterone cypionate 200 mg/ml injections to a facility located in Conshohocken, Pennsylvania, with performance required between August 31 and September 1, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with oversight and funding provided by DLA in support of its medical supply procurement...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred two thousand four hundred seventy dollars and forty-seven cents ($102,470.47) to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a one-day period of performance from September 25 to 26, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will...
- The Defense Logistics Agency awarded a $164 firm fixed price delivery order to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 23, 2023 in support of DLA's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime without involvement of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $54,720 to Amerisourcebergen Drug Corporation to supply testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. The Defense Logistics Agency facilitates procurement across the Department of Defense to support its various missions. Amerisourcebergen, a...
- The Defense Logistics Agency awarded a $75,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a one-day period of performance from September 11-12, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $766.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will supply the agreed quantities of the injectable pharmaceutical to the DLA from its facility in Conshohocken, Pennsylvania, with performance required from July 26-27, 2023. The delivery order was issued under an existing DLA-wide contract vehicle available for medical commodities....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at two hundred four thousand eight hundred thirty dollars and eighty-three cents ($204,830.83) to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 3, 2023 in support of the Defense Department's medical supply needs. Amerisourcebergen Corporation...
- The Defense Logistics Agency awarded a $182,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. Performance will take place in Conshohocken, Pennsylvania from June 23 through June 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for testosterone injections supports the DLA's mission to provide critical medical commodities to military treatment facilities on short...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred thirty-two thousand two hundred twenty-four dollars to Amerisourcebergen Drug Corporation for testosterone cypionate 200 mg/ml injections. As the prime contractor, Amerisourcebergen will supply the pharmaceutical products to the DLA under a one-day period of performance in Conshohocken, Pennsylvania, beginning and ending on September 19-20, 2023. No subcontractors or additional context were provided...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV45WDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred twenty thousand one hundred eighteen dollars to Amerisourcebergen Drug Corporation. To be performed over a one-day period in September 2023, the order is for the delivery of testosterone cypionate 200 mg/ml injections to a facility in Conshohocken, Pennsylvania in support of DLA programs. As the prime contractor, Amerisourcebergen Drug Corporation will leverage its corporate parent Amerisourcebergen Corporation's distribution network to fulfill agency requirements for this pharmaceutical product on schedule according to the terms of the award.
Generated 12/21/23, 10:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $120 | 9/21/23 |